SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES

To date, cancer diseases are one of the leading causes of mortality and morbidity in the world. Recent advances in understanding the molecular genetic mechanisms of oncogenesis and anti-cancer immune responses open new opportunities for the development of novel effective therapeutic strategies again...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	T. S. Nepomnyashchikh, E. V. Gavrilova, R. A. Maksyutov
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2019
Materias:	cancer immune response immunotherapy oncolytic viruses cancer vaccines allograft models xenograft models laboratory animals Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/c797440fe6244527ad58c8df1f2d8ed5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c797440fe6244527ad58c8df1f2d8ed5
record_format	dspace
spelling	oai:doaj.org-article:c797440fe6244527ad58c8df1f2d8ed52021-11-18T08:03:48ZSELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES1563-06252313-741X10.15789/1563-0625-2019-2-221-230https://doaj.org/article/c797440fe6244527ad58c8df1f2d8ed52019-05-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1580https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XTo date, cancer diseases are one of the leading causes of mortality and morbidity in the world. Recent advances in understanding the molecular genetic mechanisms of oncogenesis and anti-cancer immune responses open new opportunities for the development of novel effective therapeutic strategies against cancer diseases; the strategies that would be more specific to tumor cells and less toxic to the host. Immunotherapeutic anti-cancer vaccines and oncolytic viruses are among the most promising approaches of this kind. For rapid and reliable screening and preclinical testing of new therapeutic approaches the relevant animal models are of critical importance. Such models provide the ability to partially reproduce tumor microenvironment and vascularization, as well as to reproduce at some extent the immune system reactions. Allograft and xenograft tumor models are the most common in cancer research. Allogenic transplantation involves the cancer cells or tumor fragments transfer between the organisms of the same species. Xenoplastic transplantation involves the transfer of tumor cells or tissues between the organisms of distinct species. Both tumor cell lines and patient-derived tumor cells and fragments obtained with biopsy can be used for xenotransplantation. Over the past decades the researchers developed numerous strains of immunodeficient mice and rats, suitable for xenografting human tumors. However, despite the widespread of immunodeficient laboratory animals as in vivo models in experimental oncology, these models do also have significant limitations associated with inability to fairly reproduce the tumor microenvironment and human immune system functions in mice, and also with the development of graft versus host reactions. Thus, when planning the experiments, it is necessary to carefully analyze all the advantages and disadvantages of animal strains, supposed to be used in experimental oncology studies.T. S. NepomnyashchikhE. V. GavrilovaR. A. MaksyutovSPb RAACIarticlecancerimmune responseimmunotherapyoncolytic virusescancer vaccinesallograft modelsxenograft modelslaboratory animalsImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 21, Iss 2, Pp 221-230 (2019)
institution	DOAJ
collection	DOAJ
language	RU
topic	cancer immune response immunotherapy oncolytic viruses cancer vaccines allograft models xenograft models laboratory animals Immunologic diseases. Allergy RC581-607
spellingShingle	cancer immune response immunotherapy oncolytic viruses cancer vaccines allograft models xenograft models laboratory animals Immunologic diseases. Allergy RC581-607 T. S. Nepomnyashchikh E. V. Gavrilova R. A. Maksyutov SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
description	To date, cancer diseases are one of the leading causes of mortality and morbidity in the world. Recent advances in understanding the molecular genetic mechanisms of oncogenesis and anti-cancer immune responses open new opportunities for the development of novel effective therapeutic strategies against cancer diseases; the strategies that would be more specific to tumor cells and less toxic to the host. Immunotherapeutic anti-cancer vaccines and oncolytic viruses are among the most promising approaches of this kind. For rapid and reliable screening and preclinical testing of new therapeutic approaches the relevant animal models are of critical importance. Such models provide the ability to partially reproduce tumor microenvironment and vascularization, as well as to reproduce at some extent the immune system reactions. Allograft and xenograft tumor models are the most common in cancer research. Allogenic transplantation involves the cancer cells or tumor fragments transfer between the organisms of the same species. Xenoplastic transplantation involves the transfer of tumor cells or tissues between the organisms of distinct species. Both tumor cell lines and patient-derived tumor cells and fragments obtained with biopsy can be used for xenotransplantation. Over the past decades the researchers developed numerous strains of immunodeficient mice and rats, suitable for xenografting human tumors. However, despite the widespread of immunodeficient laboratory animals as in vivo models in experimental oncology, these models do also have significant limitations associated with inability to fairly reproduce the tumor microenvironment and human immune system functions in mice, and also with the development of graft versus host reactions. Thus, when planning the experiments, it is necessary to carefully analyze all the advantages and disadvantages of animal strains, supposed to be used in experimental oncology studies.
format	article
author	T. S. Nepomnyashchikh E. V. Gavrilova R. A. Maksyutov
author_facet	T. S. Nepomnyashchikh E. V. Gavrilova R. A. Maksyutov
author_sort	T. S. Nepomnyashchikh
title	SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
title_short	SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
title_full	SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
title_fullStr	SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
title_full_unstemmed	SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES
title_sort	selected aspects of allo- and xenograft model applications for developing novel anti-cancer vaccines and oncolytic viruses
publisher	SPb RAACI
publishDate	2019
url	https://doaj.org/article/c797440fe6244527ad58c8df1f2d8ed5
work_keys_str_mv	AT tsnepomnyashchikh selectedaspectsofalloandxenograftmodelapplicationsfordevelopingnovelanticancervaccinesandoncolyticviruses AT evgavrilova selectedaspectsofalloandxenograftmodelapplicationsfordevelopingnovelanticancervaccinesandoncolyticviruses AT ramaksyutov selectedaspectsofalloandxenograftmodelapplicationsfordevelopingnovelanticancervaccinesandoncolyticviruses
_version_	1718422381346684928

SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES

Ejemplares similares